TGF-1 and IFN- stimulate mouse macrophages to express ... - CiteSeerX

TGF-␤1 and IFN-␥ stimulate mouse macrophages to express BAFF via different signaling pathways Hyun-A Kim,* Seong-Hyun Jeon,* Goo-Young Seo,* Jae-Bong Park,† and Pyeung-Hyeun Kim*,‡,1 *Department of Molecular Bioscience, School of Bioscience and Biotechnology, and ‡Vascular System Research Center, Kangwon National University, Chunchon, Republic of Korea; and †Department of Biochemistry, College of Medicine, Hallym University, Chunchon, Republic of Korea

Abstract: B cell-activating factor belonging to the TNF family (BAFF) is primarily expressed by macrophages and dendritic cells and stimulates the proliferation, differentiation, and survival of B cells and their Ig production. In the present study, we examined the pathways by which TGF-␤1 and IFN-␥ induce BAFF expression to see if TGF-␤1 and IFN-␥ regulate B cell differentiation via macrophages. We found that TGF-␤1 stimulated mouse macrophages to express BAFF and that a typical TGF-␤ signaling pathway was involved. Thus, Smad3 and Smad4 promoted BAFF promoter activity, and Smad7 inhibited it, and the BAFF promoter was shown to contain three Smad-binding elements. Importantly, TGF-␤1 enhanced the expression of membrane-bound and soluble forms of BAFF. IFN-␥ further augmented TGF-␤1-induced BAFF expression. IFN-␥ caused phosphorylation of CREB, and overexpression of CREB increased IFN-␥-induced BAFF promoter activity. Furthermore, H89, a protein kinase A (PKA) inhibitor, abrogated the promoter activity. Neither Stat1␣ (a well-known transducing molecule of IFN-␥) nor AG490 (a JAK inhibitor) affected BAFF expression in response to IFN-␥. Taken together, these results demonstrate that TGF-␤1 and IFN-␥ up-regulate BAFF expression through independent mechanisms, i.e., mainly Smad3/4 and PKA/CREB, respectively. J. Leukoc. Biol. 83: 1431–1439; 2008.

tion (CSR) [7–9]. Activation-induced deaminase (AID) is expressed during CSR, and it has been demonstrated that BAFF induces AID expression [10 –12]. In addition, transgenic mice overexpressing BAFF have increased numbers of peripheral B cells and elevated serum Ig levels and develop symptoms of autoimmune disease [7, 13, 14]. Conversely, BAFF-deficient mice display severely impaired B cell maturation beyond the immature, transitional stage with significant defects in peripheral B cell numbers and antibody responses [15–17]. IFN-␥ is known to stimulate BAFF synthesis by monocytes, macrophages, DCs, and neutrophils [10, 18, 19], and IL-10, IFN-␣, and bacterial components such as LPS and peptidoglycan also enhance BAFF expression [5, 10, 18]. On the other hand, TGF-␤, a multifunctional peptide, promotes switching to IgA and IgG2b in mouse and human B cells [20 –22]. We have demonstrated that Smad3/4, Runt-related transcription factor 3 (Runx3), and p300 are important mediators of TGF-␤-induced germline-␣ and -␥2b transcription and of the subsequent IgA and IgG2b CSR [23–25]. However, it is not known if the stimulatory action of TGF-␤1 on macrophages is implicated in B cell activation and differentiation [26, 27]. In this study, we explored the effects of TGF-␤1 along with IFN-␥ on BAFF expression by mouse macrophages to see if TGF-␤1 and IFN-␥ regulate B cell differentiation indirectly by influencing macrophages. We found that TGF-␤1 and IFN-␥ stimulated macrophages to express BAFF. In essence, TGF-␤1 induced BAFF expression via Smad3/4, and protein kinase A (PKA) and CREB were major mediators of the BAFF expression induced by IFN-␥.

Key Words: Smad 䡠 CREB 䡠 promoter

MATERIALS AND METHODS INTRODUCTION It is generally accepted that Th cells have the most effect on B cell maturation and differentiation once the B cells recognize protein antigens. However, it is increasingly clear that APCs directly affect B cells. Thus, dendritic cells (DCs) enhance B cell proliferation and differentiation [1–3], and macrophages also regulate B cell responses [4, 5]. B cell-activating factor belonging to the TNF family (BAFF; also known as TALL-1, THANK, BLyS, and zTNF4), derived from macrophages and DCs, is thought to play a key role in such effects [6]. It is involved in cell survival and maturation, germinal center formation, antibody production, and class-switching recombina0741-5400/08/0083-1431 © Society for Leukocyte Biology

Reagent TGF-␤1 and IFN-␥ were purchased from R&D Systems (Minneapolis, MN, USA). 2,2⬘-Azinobis-(3-ethylbenzthiazoline sulphonic acid) (ABTS), H89, LPS, AG490, and forskolin were from Sigma Chemical Co. (St. Louis, MO, USA). The antibodies used in BAFF ELISA and FACS were purchased from Alexis Biosystems (San Diego, CA, USA).

1 Correspondence: Department of Molecular Bioscience, School of Bioscience and Biotechnology, Kangwon National University, Chunchon 200-701, Republic of Korea. E-mail: [email protected] Received October 8, 2007; revised January 4, 2008; accepted February 18, 2008. doi: 10.1189/jlb.1007676

Journal of Leukocyte Biology Volume 83, June 2008 1431

Mice BALB/c mice were purchased from Orient Co. Ltd. (Gyeonggi-do, Korea) and maintained on an 8:16-h light:dark cycle in an animal environmental control chamber (Myung Jin Inst. Co., Korea). They were fed Purina Laboratory Rodent Chow 5001 ad libitum. Mice that were 8 –12 weeks old were used in this study. Animal care was in accordance with the institutional guidelines of Kangwon National University (Korea).

Cell culture The murine macrophage cell line RAW264.7 was cultured in DMEM (2 mM L-glutamine, 100 U/ml penicillin, 100 ␮g/ml streptomycin) plus 10% FBS (HyClone Labs, Logan, UT, USA) in a humidified CO2 incubator. Bone marrow stem cells were isolated from BALB/c mouse femurs and cultured with 10 ng/ml M-CSF (R&D Systems) for 7 days. Thereafter, expression of the macrophage surface marker CD11b was detected by using mouse anti-CD11b mAb (Dinona Inc., Seoul, Korea)—⬇90% when analyzed by FACS. In the proliferation assay, RAW 264.7 cells were incubated with TGF-␤1 (1 ng/ml), and cell proliferation was measured with the Cell Counting Kit-8 reagent (Dojindo Laboratories, Tokyo, Japan).

ELISA for mouse BAFF Cells were cultured in various conditions, and supernatant BAFF levels were determined by ELISA. Briefly, anti-mouse BAFF antibody (2 ␮g/ml) was added to 96-well U-bottom polyvinyl microplates. After incubation overnight at 4°C, the plates were washed and blocked with 1% gelatin for 1 h. Supernatant samples (50 ␮l) or standard protein (mouse recombinant BAFF) diluted in 0.5% gelatin were added to the wells. After incubation for 1 h at 37°C, the plates were washed again, and 2 ␮g/ml biotinylated anti-mouse BAFF antibody was added for 1 h at 37°C. The plates were then washed and incubated with streptavidin-HRP (R&D Systems) for a further hour. After washing, 0.2 mM ABTS was added to the wells, and 10 min later, the colorimetric reaction was measured at 405 nm with a VERSAmax ELISA reader (Molecular Devices, Sunnyvale, CA, USA).

Flow cytometry Cultured cells were washed with HBSS and resuspended in 0.01 M PBS at a density of 1 ⫻ 106 cells/ml. Anti-mouse BAFF antibody was added to the cell suspension and the cells were placed at 4°C for 30 min. After washing, they were incubated with PE-conjugated anti-rat IgG antibody (Becton Dickinson, San Jose, CA, USA) at 4°C for 30 min, washed three times with 0.01 M PBS, and resuspended in 0.01 M PBS–1% formalin. Cytofluorometric analysis was carried out with a FACScan (Becton Dickinson, Mountain View, CA, USA).

RT-PCR RNA preparation, RT, and PCR were performed as described previously [23]. Primers for PCR were synthesized by Bioneer Corp. (Seoul, Korea). The primers for mouse BAFF were: forward primer, 5⬘-GCC GCC ATT CTC AAC ATG AT-3⬘, and reverse primer, 5⬘-TTA GGG CAC CAA AGA AGG TG-3⬘. Primers spanning the mouse BAFF gene amplified the two reported mRNA forms: BAFF and ⌬BAFF, as the expected 468 and 409 bp products, respectively. PCR products were separated on a 2% agarose gel and photographed. Band intensities were quantified using Scion Image software (Scion Corp., Frederick, MD, USA).

Plasmid construction A mouse BAFF promoter DNA fragment (–703⬃⫹210, 912 bp) was amplified from mouse spleen genomic DNA by PCR. The PCR primers were based on the sequences in GenBank (Accession No. NT_039455). It was subcloned into pGL3 (Promega, Madison, WI, USA) using KpnI and Bgl⌱⌱ restriction enzyme sites, and this BAFF promoter reporter was designated pBAFF. MatInspector software (Genomatix Software, Munich, Germany) and TFSEARCH, Version 1.3 (Computational Biology Research Center, Japan), were used to identify putative transcription factor-binding motifs. Mutations were introduced into the putative Smad-binding elements (SBEs) of pBAFF using a QuikChangeTM site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). The mammalian expression vectors Smad3, Smad4, and Smad7, generously provided by Dr.

1432

Journal of Leukocyte Biology Volume 83, June 2008

Masahiro Kawabata (Department of Biochemistry, The Cancer Institute, Tokyo, Japan), were subcloned into N-terminal Flag-tagged pcDNA3. pCMV2-CREB (a rat CREB expression plasmid) was obtained from Dr. Paul R. Dobner (University of Massachusetts Medical School, Worcester, MA, USA). Dominant-negative (DN)-CREB with its serine 133 phosphorylation site mutated to alanine was made as described previously [28]. The expression plasmid containing the cDNA for Stat1 and DN-Stat1, which were subcloned into plasmid RC/CMV, was generously provided by Dr. James Darnell Jr. (Laboratory of Molecular Cell Biology, The Rockefeller University, New York, NY, USA).

Transfection and luciferase assay RAW264.7 cells were transfected using GeneSHUTTLE-20 according to the manufacturer’s protocol (Qbiogene, Irvine, CA, USA). Reporter plasmids were cotransfected with expression plasmids and pCMV␤-galactosidase (pCMV␤gal; Stratagene), and luciferase and ␤-gal assays were performed as described [23].

Cell lysis and immunoblotting For Western blot analysis, total cell lysates were subjected to SDS-PAGE under reducing conditions, and proteins were transferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA, USA). Specific immunodetection was carried out by incubation with anti-CREB antibody (Cell Signaling Technology, Beverly, MA, USA), antiphospho-CREB antibody (Cell Signaling Technology), or anti-Flag antibody (Sigma Chemical Co.), followed by peroxidase-conjugated goat anti-mouse IgG (Pierce, Rockford, IL, USA) or goat anti-rabbit IgG (Pierce). The presence of specific proteins was revealed by chemiluminescence assays with a Supersignal detection kit (Pierce).

Immunofluorescence RAW 264.7 cells were grown on round coverslips and fixed with 3.7% paraformaldehyde in 0.01 M PBS for 30 min. They were permeabilized with 0.2% Triton X-100 in 0.01 M PBS for 15 min and incubated with a blocking solution (2% BSA in 0.01 M PBS). They were then incubated with anti-BAFF antibody (Alexis Biosystems) for 2 h at room temperature and further with FITC-conjugated anti-rat IgG (Pierce) for 30 min in the blocking solution. The stained cells were mounted on glass slides with Gel/Mount and observed with a laser-scanning confocal microscope (Fluoview, FV-300, Olympus, Melville, NY, USA).

Chromatin immunoprecipitation (ChIP) assays ChIP assays were performed using a ChIP assay kit (Upstate Biotechnology, Inc., Lake Placid, NY, USA). RAW264.7 cells (1⫻106) were fixed with 1% formaldehyde, washed, resuspended in lysis buffer, and sonicated. After removing cell debris by centrifugation, the supernatant was diluted tenfold with ChIP dilution buffer and precleared with a salmon sperm DNA/Protein A agarose–50% slurry. The supernatant fraction was transferred to a fresh tube with 10 ␮g/ml anti-Smad3 antibody (Zymed Laboratories Inc., San Francisco, CA, USA) and incubated overnight at 4°C. Salmon sperm DNA/Protein A agarose–50% slurry (60 ␮l) was added to the immune complexes, and after incubation for 1 h at 4°C, the supernatant was discarded. The histone-DNA cross-links were reversed by digestion with 2 ␮l 10 mg/ml proteinase K, and the DNA was extracted, dissolved in 20 ␮l Tris/EDTA buffer, and subjected to PCR. The primer sequences were the following: pBAFF promoter region, forward, 5⬘-CCT TCC AGA CCA GGA AAG AC-3⬘, and reverse, 5⬘-GTG CTT GAG TCT GAA CTG CAT-3⬘, and the products were resolved by electrophoresis on 2% agarose gels.

Preparation of oligonucleotide probes The sequences of the upper strands of the double-stranded oligonucleotides used in EMSAs are given below. SBE1 probe (– 691 to – 662): 5⬘-CCA GCC AGC CTT CCA GAC CAG GAA AGA CTA-3⬘; SBE2 probe (– 633 to – 604): 5⬘-CCA AGC CCA GGC ACA GAC TGA GGA CAT CCT-3⬘; SBE3 probe (–304 to –273): 5⬘-CCA AAT GCA GTT CAG ACT CAA GCA CTG AGC-3⬘. 32 P-end-labeled oligonucleotides were prepared using the Gel Shift assay system (Promega).

http://www.jleukbio.org

EMSA DNA binding reactions were performed in 20 ␮l reaction volumes containing 50 fmol end-labeled dsDNA probe and 2 ␮g nuclear extract in the buffer of the Gel Shift assay system (Promega). The reaction mixtures were incubated at room temperature for 30 min and then loaded onto 6% native polyacrylamide gels and run in 0.5⫻ Tris– boric acid–EDTA buffer at 130 V for 4 h. For competition experiments, cold probe (a tenfold molar excess of unlabeled oligonucleotide) was added to the complete mixture with the probe added last.

Statistical analysis Statistical differences between experimental groups were determined by ANOVAs, and values of P ⬍ 0.01 by unpaired two-tailed Student’s t-test were considered significant.

RESULTS Effects of TGF-␤1 on the expression of BAFF by mouse macrophages Macrophages are involved in B cell activation and differentiation [4, 6], and BAFF is one of the important factors expressed by macrophages [5, 10, 18, 29]. Ig isotype switching is a critical event in B cell differentiation, in which TGF-␤1 acts as a powerful switching factor for the IgA and IgG2b mouse isotypes [22, 30]. However, it is not known if the action of TGF-␤1 on macrophages is associated with B cell activation and differentiation. To explore the possibility that TGF-␤1 regulates BAFF expression in mouse macrophages, we exam-

ined the effect of TGF-␤1 on levels of endogenous BAFF transcripts in parallel to that of IFN-␥, which is known to induce BAFF expression in macrophages [10, 18]. As shown in Figure 1A, TGF-␤1 increased the level of BAFF mRNA as much as did IFN-␥ in the macrophage cell line. In contrast, neither LPS (a general macrophage activator) nor IL-2 has this effect. TGF-␤1 (1 ng/ml) was optimal, and BAFF transcripts were detectable by 6 h after stimulation. BAFF exists in a secreted and a membrane-bound form [29, 31]. TGF-␤1 was found to increase the production of BAFF by macrophages for at least 72 h (Fig. 1B, left panel) in the absence of any substantial effect on cell proliferation (Fig. 1B, right panel), indicating that it actually regulates macrophage BAFF gene expression. TGF-␤1 also stimulated BAFF expression at the mRNA and protein levels in primary bone marrow-derived macrophages (Fig. 1C).

Effects of overexpressed Smad3 and Smad4 on TGF-␤1-induced BAFF expression As Smad3 and Smad4 are well-known intermediates in the TGF-␤ signaling pathway [32–34], we asked whether they mediated the BAFF expression. Overexpression of Smad3/4 enhanced the TGF-␤1-induced BAFF mRNA expression, and overexpression of a DN-Smad3 abrogated BAFF transcription in a dose-dependent manner (Fig. 2A). Overexpression of Smad3/4 also enhanced TGF-␤1-induced BAFF secretion (Fig. 2B). In addition, we examined the effect of TGF-␤1 on the

Fig. 1. TGF-␤1 stimulates mouse macrophages to express BAFF. (A) Effect of TGF-␤1 on BAFF transcripts in mouse macrophages. Effects of various potential stimuli on BAFF transcription by mouse macrophages (left panel). A mouse macrophage cell line, RAW264.7, was incubated with TGF-␤1 (1 ng/ml), LPS (10 ␮g/ml), IFN-␥ (10 ng/ml), or IL-2 (100 IU/ml) for 24 h. Dose response of BAFF transcription to TGF-␤1 (middle panel). RAW264.7 was treated with TGF-␤1 (0.04, 0.2, 1, 5 ng/ml) for 24 h. Effect of TGF-␤1 on BAFF transcripts as a function of time (right panel). TGF-␤1 (1 ng/ml) was added to cultures for the indicated times. BAFF mRNA levels were determined by RT-PCR. Fold increases represent relative amounts of BAFF DNA normalized with the expression of ␤-actin cDNA using Scion Image Analysis [National Institutes of Health (NIH) software]. (B) Effect of TGF-␤1 on BAFF secretion. RAW264.7 cells were treated TGF-␤1 (1 ng/ml), and soluble BAFF was measured by ELISA (left panel). Effects of TGF-␤1 on the proliferation of mouse macrophages (right panel). RAW264.7 cells were incubated with TGF-␤1 (1 ng/ml), and cell proliferation was assessed using a Cell Counting Kit-8 (Dojindo Laboratories). Data are means of triplicate samples ⫾ SEM. (C) Effect of TGF-␤1 on BAFF expression by bone marrow-derived macrophages (M␾). Freshly isolated bone marrow stem cells were differentiated as described in Materials and Methods and incubated with TGF-␤1 (1 ng/ml) for 24 h. Levels of BAFF transcripts were determined by RT-PCR (left panel). For PCR, cDNAs from each sample were prepared to 1:1, 1:3, and 1:9 dilutions. BAFF secretion was measured by ELISA. Data are means of triplicate samples ⫾ SEM; *, statistical significance when compared with media controls (P⬍0.01).

Kim et al. BAFF expression in TGF-␤1/IFN-␥-activated M␾

1433

Fig. 2. Smad3/4 mediates TGF-␤1-induced BAFF expression in mouse macrophages. (A) RAW264.7 cells (1⫻106) were transfected with the expression plasmids Smad3/4 (each 1 ␮g) or DN-Smad3 (1, 3, 9 ␮g) and stimulated with TGF-␤1 (1 ng/ml) for 24 h. Levels of BAFF transcripts were determined by RT-PCR. Fold increases represent relative BAFF DNA levels normalized with the expression of ␤-actin cDNA by Scion Image Analysis software. (B) BAFF secretion by Smad3/4-transfected RAW264.7 was measured by ELISA after 72 h incubation with TGF-␤1. Data are means of triplicate samples ⫾ SEM; *, P ⬍ 0.01.

expression of membrane-bound BAFF by FACS and found that it progressively increased the frequency of BAFF-expressing cells as well as the intensity of their fluorescence (Table 1). In contrast, in the presence of TGF-␤1, overexpression of Smad3/4 only marginally increased the frequency of BAFF-expressing cells but markedly increased the fluorescence intensity of the BAFFexpressing cells, indicating that the transfected Smad3/4 acted specifically on cells already committed to make BAFF. Finally, DN-Smad3 completely abolished the increase in frequency of BAFF-expressing cells promoted by TGF-␤1 and the increase in their fluorescence intensity. Taken together, these results show that Smad3 and Smad4 are critical mediators of TGF-␤1-induced BAFF expression in mouse macrophages.

Construction and analysis of mouse BAFF promoters To elucidate BAFF transcriptional regulation by TGF-␤1 and Smad3/4, we constructed a mouse BAFF promoter reporter, pBAFF. There are at least three putative SBEs (see Fig. 3B) within the putative BAFF promoter region (TFSEARCH, Version. 1.3, and MatInspector, Version 3.0, Genomatix Software). We first examined the effect of overexpressed Smad3/4 on TABLE 1.

Effects of TGF-␤1 and Smad3/4 on Surface BAFF Expressiona Surface BAFF expression

Exp.

I II III

TGF-␤1 ⫺ ⫹ ⫹ ⫹ ⫺ ⫹ ⫹ ⫺ ⫹ ⫹

(48 (48 (72 (96 (48 (48 (48 (48 (48 (48

h) h) h) h) h) h) h) h) h) h)

Smad3/4

DN-Smad3

%

– – – – – – ⫹ – – –

– – – – – – – – – ⫹

0.9 1.6 3.6 4.2 2.0 3.6 5.5 3.2 7.8 2.0

TGF-␤1 and IFN-␥ in combination increase BAFF expression by mouse macrophages

(Fold (Fold inc.) F.I.b inc.) 1.0 1.8 4.1 4.8 1.0 1.4 1.8 1.0 2.5 0.5

19 148 415 595 16 66 163 12 80 15

1.0 7.7 21.7 31.2 1.0 4.1 10.0 1.0 6.5 1.2

a RAW264.7 cells (1⫻106) were transfected with Smad3/4 (each 1 ␮g) or DN-Smad3 (3 ␮g) and incubated with TGF-␤1 (1 ng/ml) as indicated. Surface BAFF expression was analyzed by FACS by using anti-BAFF antibody. b F.I., Fluorescence intensity. Fold inc., Fold increase.

1434

pBAFF reporter activity in RAW264.7. As shown in Figure 3A, TGF-␤1 stimulated reporter activity approximately twofold, and this effect was augmented by overexpressed Smad3/4. On the other hand, overexpression of Smad7, a TGF-␤-inducible antagonist of TGF-␤ signaling [35], led to complete abolition of Smad3/4-mediated promoter activity. To determine which of the three potential SBEs are important for promoter activity, we substituted each of the CAGAC elements (Fig. 3B). The mutant reporters (pBAFF-mS1, pBAFF-mS2, and pBAFF-mS3) did not respond to TGF-␤1 and Smad3/4, indicating that each of these putative SBEs is indispensable for TGF-␤1-induced BAFF promoter activity. We investigated binding of Smad3 to the SBEs by ChIP assays (Fig. 4A). TGF-␤1 markedly increased binding of Smad3 to the promoter, and the binding was further enhanced by overexpression of Smad3/4. To distinguish which SBEs bind Smad3, we investigated the binding of Smad3 to three probes, each containing a different SBE by EMSA. TGF-␤1 treatment stimulated the formation of DNA–Smad3 complexes with all three probes, although binding to the second probe was relatively weak, and all of the complexes were eliminated by preincubation with a tenfold excess of cold probe (Fig. 4C). Similar results were obtained when nuclear extracts were tested with the three probes (Fig. 4D). These results reveal that all three putative SBEs are required for optimal TGF-␤1induced BAFF promoter activity.


It has been demonstrated that IFN-␥ induces BAFF expression in macrophages and DCs [10, 18], as also shown in Figure 1A. As the signaling pathways of TGF-␤1 and IFN-␥ are thought to be different, we were interested in their combined effect on BAFF gene expression. In macrophage cell line and normal bone marrow-derived macrophages, stimulation of endogenous BAFF transcription by the two cytokines proved to be greater than by either on its own (Fig. 5A), and the same effect was obtained for promoter activity (Fig. 5B). There was parallel increase of BAFF protein in the cytoplasm (Fig. 5C) and at the secretion cell supernatants (Fig. 5D). To investigate how IFN-␥ induces BAFF expression in mouse macrophages, we explored the possible involvement of Stat1, a key intermediate in IFN␥-induced gene expression [36 –38]. Unexpectedly, overexhttp://www.jleukbio.org

Fig. 3. Role of putative SBEs in mouse BAFF promoter activity. (A) Effects of TGF-␤1 and Smad on promoter activity. DNA segments –703 to ⫹210 were cloned into pGL3-basic vector as described in Materials and Methods and designated pBAFF. RAW264.7 cells (1⫻106) were transiently cotransfected with pBAFF (1 ␮g) and expression vectors coding for Smad3/4 and Smad7 (1 ␮g each). Cells were incubated with TGF-␤1 (1 ng/ml), and luciferase activity was determined 24 h later. RLA, Relative luciferase activity. (B) Effect of mutant BAFF reporters (pBAFF-mS1, -2, and -3). SBE, Putative SBE; mSBE, mutated SBE. Transfection efficiency was normalized by ␤-gal activity. Data are average luciferase (LUC) activities of three independent transfections with SEM (bars); *, P ⬍ 0.01; **, P ⬍ 0.05.

pressed Stat1␣ hardly affected endogenous BAFF transcription (Fig. 6A), and the same was true for promoter activity (Fig. 6B, left panel). Moreover, neither overexpression of DN-Stat1␣ nor AG490 (a JAK inhibitor) affected IFN-␥-induced BAFF promoter activity (Fig. 6B, right panel). Apparently, the JAK/Stat1 pathway is not involved in IFN-␥-induced BAFF transcription.

As IFN-␥ activates the PKA/CREB signaling pathway in murine peritoneal macrophages [40], we examined this pathway in our system and detected IFN-␥-activated CREB phosphorylation (Fig. 6C). Forskolin, a PKA activator, which stimulates the phosphorylation of CREB [41], was included as a positive control and also stimulated CREB phosphorylation,

Fig. 4. Smad3 specifically binds to the BAFF promoter under the influence of TGF-␤1. (A) ChIP assay for Smad3 binding. Primer pairs to amplify a 404-bp segment (– 683⬃–280 bp) encompassing SBE1, SBE2, and SBE3 were: forward, 5⬘-CCTTCCAGACCAGGAAAGACT-3⬘, and reverse, 5⬘-GTGCTTGAGTCTGAACTGCAT-3⬘. RAW264.7 cells (1⫻106) were transfected with the expression vectors coding for Smad3/4 (each 1 ␮g) and cultured with TGF-␤1 (1 ng/ml) for 12 h. Anti-Smad3 antibody was used to detect probe-bound Smad3. For PCR, cDNAs from each sample were prepared at 1:1 and 1:5 dilutions. (B) Western blotting (WB) to detect the expression of transfected Smad3. RAW264.7 cells (1⫻106) were transfected with the expression vectors coding for Smad3/4 (each 1 ␮g) and cultured with TGF-␤1 (1 ng/ml) for 12 h. Anti-Smad3 antibody was used to detect Smad3. (C) EMSA showing complexes formed with Smad3 and pBAFF probes containing SBE1 (– 691 to – 662), SBE2 (– 633 to – 604), or SBE3 (–304 to –273). (D) EMSA showing complexes formed with a TGF-␤1-induced, Smad3/4-transfected nuclear extract and pBAFF probes containing SBE1, SBE2, or SBE3. Nuclear extracts from Smad3/4-transfected RAW264.7 cells were prepared after 12 h incubation with TGF-␤1.


1435

Fig. 5. TGF-␤1 and IFN-␥ in combination increase BAFF expression in mouse macrophages. (A) Effects of TGF-␤1 and IFN-␥ on endogenous levels of BAFF transcripts. RAW264.7 cells or bone marrow-derived macrophages were incubated with TGF-␤1 (1 ng/ml) and IFN-␥ (10 ng/ml) for 24 h. Total RNA was extracted, and levels of BAFF mRNA were determined by RT-PCR. Fold increases represent relative amounts of BAFF DNA normalized with the expression of ␤-actin cDNA using Scion Image Analysis (NIH software). (B) Effects of TGF-␤1 and IFN-␥ on BAFF promoter activity. RAW264.7 cells were transfected with the pBAFF reporter (1 ␮g) and cultured with TGF-␤1 (1 ng/ml) and IFN-␥ (10 ng/ml) for 24 h. Promoter activity was measured using the luciferase reporter assay, and transfection efficiency was normalized by ␤-gal activity. Data are average luciferase activities of three independent transfections with SEM (bars). (C) Localization of BAFF protein by confocal laser microscopy. RAW264.7 cells were cultured with TGF-␤1 (1 ng/ml) and IFN-␥ (10 ng/ml) for 24 h. Anti-BAFF antibody was used to detect cytoplasmic BAFF. (D) Effect of TGF-␤1 and IFN-␥ on BAFF secretion. Cells were cultured with TGF-␤1 (1 ng/ml) and IFN-␥ (10 ng/ml) for 72 h, culture supernatants were harvested, and levels of BAFF were measured by ELISA. Data are means of triplicate samples ⫾ SEM; *, P ⬍ 0.01.

and preincubation with H89, a PKA inhibitor, inhibited CREB phosphorylation. Moreover, as shown in Figure 6D, overexpression of CREB increased IFN-␥-induced BAFF promoter activity twofold, and DN-CREB abrogated this effect. Taken together, these results suggest that IFN-␥ stimulates BAFF expression mainly through the PKA–CREB pathway. We are currently analyzing CREB-binding elements, i.e., CREs within the cloned BAFF promoter sequences. Thus far, we have demonstrated that TGF-␤1 and IFN-␥ stimulate mouse macrophages to express BAFF, mainly via Smad3/4 in the first case and PKA/CREB in the second. Cytokines often cross-talk during their signal transduction. Thus, we assessed the roles of Smad3/4 and PKA/CREB in BAFF expression in the presence of both cytokines. Overexpressed DN-Smad3 and H89 each only partially abrogated the combined effect of the two cytokines on promoter activity (Fig. 7). Meanwhile, overexpression of DN-Smad3 together with H89 treatment completely eliminated the promoter activity. These results confirm that TGF-␤1 and IFN-␥ stimulate BAFF expression via different signaling pathways. 1436


DISCUSSION Although BAFF is believed to be the most important macrophage-derived B cell-activating factor [5, 6], the pathway involved in BAFF expression is not clear. In the present study, we demonstrate that TGF-␤1 stimulates mouse macrophages to produce BAFF and that a typical TGF-␤ signaling pathway is involved [42]. Smad3 and Smad4 promoted BAFF expression, and Smad7 inhibited it in the mouse macrophage cell line, and we showed that Smad3 binds three putative SBEs in the promoter and that these elements are indispensable for promoter activity. More importantly, normal bone marrow-derived macrophages also responded to TGF-␤1. It is thus clear that TGF-␤1 is an important stimulant of BAFF expression by mouse macrophages and that Smad3/4 is mainly responsible for mediating the TGF-␤1-induced BAFF expression. It is known that the DNA-binding specificity of Smad proteins is relatively low. Thus, the individual Smad proteins must cooperate with other DNA-binding proteins to elicit specific transcriptional responses [43, 44]. In this context, we have http://www.jleukbio.org

Fig. 6. CREB mediates IFN-␥-induced BAFF expression by mouse macrophages. (A) Effects of overexpressed Stat1␣ on the expression of endogenous BAFF transcripts. RAW264.7 cells were transiently transfected with Stat1␣ (1 ␮g) and incubated with IFN-␥ (10 ng/ml) for 24 h. Levels of BAFF transcripts were determined by RT-PCR. Fold increase represents relative amounts of BAFF DNA normalized with the ␤-actin cDNA. (B) Effects of overexpressed Stat1␣, DN-Stat1␣, and AG490 on BAFF promoter activity. RAW264.7 cells were transiently cotransfected with pBAFF and expression vectors coding for Flag-Stat1␣ and Flag-DN-Stat1␣ (each 1 ␮g). Cells were then cultured with IFN-␥ (10 ng/ml) for 24 h. Cells were preincubated with AG490 (25 ␮M) for 1 h. Transcriptional activity was measured using the luciferase reporter assay, and transfection efficiency was normalized with ␤-gal activity (left panel). Data are average luciferase activities of three independent transfections with SEM (bars). Western blotting to detect the expression of transfected Stat1␣ and DN-Stat1␣ using anti-Flag antibody (right panel). Not shown here, AG490 (25 ␮M) successfully inhibited the IL-4-induced, Stat-mediated target gene expression [39], and overexpression of DN-Stat1␣ (1 ␮g) markedly restored the Ig germline-␣ promoter activity, which was repressed by IFN-␥ through Stat1. (C) IFN-␥ induces CREB phosphorylation via PKA. RAW264.7 cells were preincubated with H89 (10 ␮M) for 1 h and incubated with IFN-␥ (10 ng/ml) and forskolin (10 ␮M). Phosphorylated CREB (p-CREB) and total CREB (t-CREB) were detected by Western blotting. (D) H89 and DN-CREB abrogate IFN-␥-induced, CREB-mediated BAFF promoter activity. RAW264.7 cells were transiently cotransfected with pBAFF and CREB or DN-CREB (each 1 ␮g). They were then treated with H89 (10 ␮M) for 1 h when it was required and incubated with IFN-␥ (10 ng/ml) for 24 h. Data are average luciferase activities of three independent transfections with SEM (bars); *, P ⬍ 0.01.

demonstrated that Runx3 synergizes with Smad3/4 to induce Ig germline-␣ transcription, leading to IgA isotype switching [24]. In addition, hypoxia-inducible factor-1␣ cooperates with Smad3/4 to mediate TGF-␤1-induced vascular endothelial growth factor transcription in mouse macrophages [45]. We have tested the possible involvement of Runx3, activating transcription factor 2, AP-1, specificity protein 1, and NF-␬B in Smad3/4-mediated BAFF promoter activity, as these DNAbinding proteins have been reported to be involved in Smad3mediated TGF-␤ target gene expression [44, 46 –51], and in particular, NF-␬B is involved in BAFF transcriptional activation in EBV-infected and malignant human B cells [52, 53]. However, none of them had much effect on promoter activity (data not shown). We found that TGF-␤1 and IFN-␥ increased the expression of membrane-bound and soluble forms of BAFF. Further, Smad3/4 augmented the expression of both forms in

macrophages stimulated with TGF-␤1. These results suggest that expression of the two BAFF forms is coordinately regulated. In this regard, it is noteworthy that overexpression of Smad3/4 greatly increased the amount of membranebound BAFF in cells already committed to make it by exposure to TGF-␤1. What is the physiological meaning of this phenomenon? It has been proposed that soluble BAFF is derived from the membrane-bound form in human mononuclear cells [18]. We suggest therefore that TGF-␤1 first induces the production of membrane-bound BAFF, and the soluble form is then derived from it. BAFF is known to induce AID and Ig CSR in B cells [11, 12], and we found that the soluble form of BAFF derived from TGF-␤1-activated macrophages actually increases AID expression in mouse B cells (Supplemental Fig. 1). These results suggest that TGF-␤1 contributes indirectly to B cell Ig isotype switching by inducing macrophages to produce BAFF.


1437

ACKNOWLEDGMENTS This work was supported by a Basic Research Program grant (No. R01-2006-000-11127-0) from the Korea Science and Engineering Foundation and by the second stage of the Brain Korea 21 program. It was carried out in facilities of the Vascular System Research Center and Institute of Bioscience and Biotechnology at Kangwon National University.

REFERENCES

Fig. 7. Effects of DN-Smad3 and H89 on BAFF promoter activity under the influence of TGF-␤1 and IFN-␥. RAW264.7 cells were transiently cotransfected with pBAFF (1 ␮g) and the expression vector coding for DN-Smad3 (1 ␮g). They were then treated with H89 for 1 h when it was required and incubated with TGF-␤1 (1 ng/ml) and IFN-␥ (10 ng/ml) for 24 h. Transcriptional activity was measured using the luciferase reporter assay, and transfection efficiency was normalized with ␤-gal activity. Data are average luciferase activities of three independent transfections with SEM (bars); *, P ⬍ 0.01.

Our findings extend an earlier study of the effect of IFN-␥ on BAFF expression, in which IFN-␥ enhanced membrane-bound and soluble forms of BAFF in normal blood monocytes [18]. It is well known that IFN-␥ responses are mainly mediated via Jak–Stat and sequence elements (IFN-␥-activated sequence) in the promoters of IFN-␥ target genes [36 –38]. However, we observed that JAK and Stat1 were not involved in the IFN-␥induced BAFF expression and that PKA/CREB was the dominant pathway. Consistent with these results, it has been reported that IFN-␥ activates the cAMP/PKA/CREB signaling pathway in murine peritoneal macrophages [40]. In fact, there is now considerable evidence for Stat1-independent pathways in IFN-␥ signaling [54 –56]. In this context, our finding that TGF-␤1 and IFN-␥ synergized in stimulating BAFF expression warrants a comment. TGF-␤ signaling involves phosphorylation of CREB [57], and CREB cooperates with Smads to mediate TGF-␤-induced germline Ig-␣ promoter activity [58]. Thus, cross-talk between the two cytokines may occur at multiple levels during BAFF gene expression. In conclusion, TGF-␤1 and IFN-␥ are well-known cytokines that induce isotype-switching recombination of IgA and IgG2a, respectively, in mouse B cells [59 – 63]. It is generally accepted that activated Th cells produce these cytokines and that they in turn directly modulate B cells. Nonetheless, there is accumulating evidence that macrophages affect B cell proliferation and differentiation [4 – 6, 10]. We have shown that TGF-␤1 and IFN-␥ stimulate mouse macrophages to produce BAFF, which can activate B cells to express AID [10 –12], and BAFF null and BAFF-receptor null mice mount poor T-dependent and T-independent antibody responses [11, 16, 64]. Therefore, our in vitro studies raise the possibility that TGF-␤1 and IFN-␥ cause macrophages to produce BAFF and so, have an important effect on Ig isotype switching in vivo. 1438


1. Dubois, B., Vanbervliet, B., Fayette, J., Massacrier, C., Van Kooten, C., Briere, F., Banchereau, J., Caux, C. (1997) Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185, 941–951. 2. Dubois, B., Massacrier, C., Vanbervliet, B., Fayette, J., Briere, F., Banchereau, J., Caux, C. (1998) Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J. Immunol. 161, 2223–2231. 3. Dubois, B., Bridon, J. M., Fayette, J., Barthelemy, C., Banchereau, J., Caux, C., Briere, F. (1999) Dendritic cells directly modulate B cell growth and differentiation. J. Leukoc. Biol. 66, 224 –230. 4. Snapper, C. M., Mond, J. J. (1996) A model for induction of T cellindependent humoral immunity in response to polysaccharide antigens. J. Immunol. 157, 2229 –2233. 5. Craxton, A., Magaletti, D., Ryan, E. J., Clark, E. A. (2003) Macrophageand dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101, 4464 – 4471. 6. Fagarasan, S., Honjo, T. (2000) T-independent immune response: new aspects of B cell biology. Science 290, 89 –92. 7. Groom, J., Kalled, S. L., Cutler, A. H., Olson, C., Woodcock, S. A., Schneider, P., Tschopp, J., Cachero, T. G., Batten, M., Wheway, J., Mauri, D., Cavill, D., Gordon, T. P., Mackay, C. R., Mackay, F. (2002) Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren’s syndrome. J. Clin. Invest. 109, 59 – 68. 8. Mackay, F., Ambrose, C. (2003) The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev. 14, 311–324. 9. Sutherland, A. P., Mackay, F., Mackay, C. R. (2006) Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas. Pharmacol. Ther. 112, 774 –786. 10. Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., Cerutti, A. (2002) DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3, 822– 829. 11. Castigli, E., Wilson, S. A., Scott, S., Dedeoglu, F., Xu, S., Lam, K. P., Bram, R. J., Jabara, H., Geha, R. S. (2005) TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 201, 35–39. 12. Yamada, T., Zhang, K., Yamada, A., Zhu, D., Saxon, A. (2005) B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination. Am. J. Respir. Cell Mol. Biol. 32, 388 –394. 13. Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., Browning, J. L. (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697–1710. 14. Dorner, T., Putterman, C. (2001) B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus. Arthritis Res. 3, 197–199. 15. Gross, J. A., Dillon, S. R., Mudri, S., Johnston, J., Littau, A., Roque, R., Rixon, M., Schou, O., Foley, K. P., Haugen, H., McMillen, S., Waggie, K., Schreckhise, R. W., Shoemaker, K., Vu, T., Moore, M., Grossman, A., Clegg, C. H. (2001) TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity 15, 289 –302. 16. Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., ShulgaMorskaya, S., Dobles, M., Frew, E., Scott, M. L. (2001) An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111–2114. 17. Rahman, Z. S., Rao, S. P., Kalled, S. L., Manser, T. (2003) Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J. Exp. Med. 198, 1157–1169. 18. Nardelli, B., Belvedere, O., Roschke, V., Moore, P. A., Olsen, H. S., Migone, T. S., Sosnovtseva, S., Carrell, J. A., Feng, P., Giri, J. G., Hilbert, D. M. (2001) Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97, 198 –204.

http://www.jleukbio.org

19. Scapini, P., Nardelli, B., Nadali, G., Calzetti, F., Pizzolo, G., Montecucco, C., Cassatella, M. A. (2003) G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J. Exp. Med. 197, 297–302. 20. Lebman, D. A., Lee, F. D., Coffman, R. L. (1990) Mechanism for transforming growth factor ␤ and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J. Immunol. 144, 952–959. 21. Kim, P. H., Kagnoff, M. F. (1990) Transforming growth factor ␤ 1 increases IgA isotype switching at the clonal level. J. Immunol. 145, 3773–3778. 22. McIntyre, T. M., Klinman, D. R., Rothman, P., Lugo, M., Dasch, J. R., Mond, J. J., Snapper, C. M. (1993) Transforming growth factor ␤ 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J. Exp. Med. 177, 1031–1037. 23. Park, S. R., Lee, J. H., Kim, P. H. (2001) Smad3 and Smad4 mediate transforming growth factor-␤1-induced IgA expression in murine B lymphocytes. Eur. J. Immunol. 31, 1706 –1715. 24. Park, S. R., Lee, E. K., Kim, B. C., Kim, P. H. (2003) p300 cooperates with Smad3/4 and Runx3 in TGF␤1-induced IgA isotype expression. Eur. J. Immunol. 33, 3386 –3392. 25. Park, S. R., Seo, G. Y., Choi, A. J., Stavnezer, J., Kim, P. H. (2005) Analysis of transforming growth factor-␤1-induced Ig germ-line ␥2b transcription and its implication for IgA isotype switching. Eur. J. Immunol. 35, 946 –956. 26. Ashcroft, G. S. (1999) Bidirectional regulation of macrophage function by TGF-␤. Microbes Infect. 1, 1275–1282. 27. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K., Flavell, R. A. (2006) Transforming growth factor-␤ regulation of immune responses. Annu. Rev. Immunol. 24, 99 –146. 28. Jeon, S. H., Chae, B. C., Kim, H. A., Seo, G. Y., Seo, D. W., Chun, G. T., Yie, S. W., Eom, S. H., Kim, P. H. (2007) The PKA/CREB pathway is closely involved in VEGF expression in mouse macrophages. Mol. Cells 23, 23–29. 29. Moore, P. A., Belvedere, O., Orr, A., Pieri, K., LaFleur, D. W., Feng, P., Soppet, D., Charters, M., Gentz, R., Parmelee, D., Li, Y., Galperina, O., Giri, J., Roschke, V., Nardelli, B., Carrell, J., Sosnovtseva, S., Greenfield, W., Ruben, S. M., Olsen, H. S., Fikes, J., Hilbert, D. M. (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260 –263. 30. Lebman, D. A., Nomura, D. Y., Coffman, R. L., Lee, F. D. (1990) Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type ␤-induced isotype switching. Proc. Natl. Acad. Sci. USA 87, 3962–3966. 31. Schneider, P., MacKay, F., Steiner, V., Hofmann, K., Bodmer, J. L., Holler, N., Ambrose, C., Lawton, P., Bixler, S., Acha-Orbea, H., Valmori, D., Romero, P., Werner-Favre, C., Zubler, R. H., Browning, J. L., Tschopp, J. (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747–1756. 32. Derynck, R., Zhang, Y. E. (2003) Smad-dependent and Smad-independent pathways in TGF-␤ family signaling. Nature 425, 577–584. 33. Moustakas, A., Souchelnytskyi, S., Heldin, C. H. (2001) Smad regulation in TGF-␤ signal transduction. J. Cell Sci. 114, 4359 – 4369. 34. Rich, J., Borton, A., Wang, X. (2001) Transforming growth factor-␤ signaling in cancer. Microsc. Res. Tech. 52, 363–373. 35. Nakao, A., Afrakhte, M., Moren, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N. E., Heldin, C. H., ten Dijke, P. (1997) Identification of Smad7, a TGF␤-inducible antagonist of TGF-␤ signaling. Nature 389, 631– 635. 36. Bach, E. A., Aguet, M., Schreiber, R. D. (1997) The IFN ␥ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15, 563–591. 37. Darnell Jr., J. E. (1997) STATs and gene regulation. Science 277, 1630 –1635. 38. Ramana, C. V., Chatterjee-Kishore, M., Nguyen, H., Stark, G. R. (2000) Complex roles of Stat1 in regulating gene expression. Oncogene 19, 2619 –2627. 39. Kim, R. J., Kim, H. A., Park, J. B., Park, S. R., Jeon, S. H., Seo, G. Y., Seo, D. W., Seo, S. R., Chun, G. T., Kim, N. S., Yie, S. W., Byeon, W. H., Kim, P. H. (2007) IL-4-induced AID expression and its relevance to IgA class switch recombination. Biochem. Biophys. Res. Commun. 361, 398 – 403. 40. Liu, L., Wang, Y., Fan, Y., Li, C. L., Chang, Z. L. (2004) IFN-␥ activates cAMP/PKA/CREB signaling pathway in murine peritoneal macrophages. J. Interferon Cytokine Res. 24, 334 –342. 41. Seamon, K. B., Daly, J. W. (1981) Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7, 201–224. 42. Heldin, C. H., Miyazono, K., ten Dijke, P. (1997) TGF-␤ signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465– 471. 43. Feng, X. H., Zhang, Y., Wu, R. Y., Derynck, R. (1998) The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coac-

44.

45.

46. 47.

48.

49. 50. 51.

52.

53.

54.

55. 56. 57. 58.

59. 60. 61.

62. 63. 64.

tivators for smad3 in TGF-␤-induced transcriptional activation. Genes Dev. 12, 2153–2163. Hanai, J., Chen, L. F., Kanno, T., Ohtani-Fujita, N., Kim, W. Y., Guo, W. H., Imamura, T., Ishidou, Y., Fukuchi, M., Shi, M. J., Stavnezer, J., Kawabata, M., Miyazono, K., Ito, Y. (1999) Interaction and functional cooperation of PEBP2/ CBF with Smads. Synergistic induction of the immunoglobulin germline C␣ promoter. J. Biol. Chem. 274, 31577–31582. Jeon, S. H., Chae, B. C., Kim, H. A., Seo, G. Y., Seo, D. W., Chun, G. T., Kim, N. S., Yie, S. W., Byeon, W. H., Eom, S. H., Ha, K. S., Kim, Y. M., Kim, P. H. (2007) Mechanisms underlying TGF-{␤}1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J. Leukoc. Biol. 81, 557–566. Zhang, Y., Feng, X. H., Derynck, R. (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-␤-induced transcription. Nature 394, 909 –913. Hoodless, P. A., Tsukazaki, T., Nishimatsu, S., Attisano, L., Wrana, J. L., Thomsen, G. H. (1999) Dominant-negative Smad2 mutants inhibit activin/ Vg1 signaling and disrupt axis formation in Xenopus. Dev. Biol. 207, 364 –379. Pardali, E., Xie, X. Q., Tsapogas, P., Itoh, S., Arvanitidis, K., Heldin, C. H., ten Dijke, P., Grundstrom, T., Sideras, P. (2000) Smad and AML proteins synergistically confer transforming growth factor ␤1 responsiveness to human germ-line IgA genes. J. Biol. Chem. 275, 3552–3560. Yamamura, Y., Hua, X., Bergelson, S., Lodish, H. F. (2000) Critical role of Smads and AP-1 complex in transforming growth factor-␤-dependent apoptosis. J. Biol. Chem. 275, 36295–36302. Lopez-Rovira, T., Chalaux, E., Rosa, J. L., Bartrons, R., Ventura, F. (2000) Interaction and functional cooperation of NF-␬ B with Smads. Transcriptional regulation of the junB promoter. J. Biol. Chem. 275, 28937–28946. Jungert, K., Buck, A., Buchholz, M., Wagner, M., Adler, G., Gress, T. M., Ellenrieder, V. (2006) Smad-Sp1 complexes mediate TGF␤-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis 27, 2392–2401. He, B., Raab-Traub, N., Casali, P., Cerutti, A. (2003) EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J. Immunol. 171, 5215– 5224. Fu, L., Lin-Lee, Y. C., Pham, L. V., Tamayo, A., Yoshimura, L., Ford, R. J. (2006) Constitutive NF-␬B and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 107, 4540 – 4548. Briscoe, J., Rogers, N. C., Witthuhn, B. A., Watling, D., Harpur, A. G., Wilks, A. F., Stark, G. R., Ihle, J. N., Kerr, I. M. (1996) Kinase-negative mutants of JAK1 can sustain interferon-␥-inducible gene expression but not an antiviral state. EMBO J. 15, 799 – 809. Gil, M. P., Bohn, E., O’Guin, A. K., Ramana, C. V., Levine, B., Stark, G. R., Virgin, H. W., Schreiber, R. D. (2001) Biologic consequences of Stat1independent IFN signaling. Proc. Natl. Acad. Sci. USA 98, 6680 – 6685. Ramana, C. V., Gil, M. P., Han, Y., Ransohoff, R. M., Schreiber, R. D., Stark, G. R. (2001) Stat1-independent regulation of gene expression in response to IFN-␥. Proc. Natl. Acad. Sci. USA 98, 6674 – 6679. Potchinsky, M. B., Weston, W. M., Lloyd, M. R., Greene, R. M. (1997) TGF-␤ signaling in murine embryonic palate cells involves phosphorylation of the CREB transcription factor. Exp. Cell Res. 231, 96 –103. Zhang, Y., Derynck, R. (2000) Transcriptional regulation of the transforming growth factor-␤ - inducible mouse germ line Ig ␣ constant region gene by functional cooperation of Smad, CREB, and AML family members. J. Biol. Chem. 275, 16979 –16985. Coffman, R. L., Lebman, D. A., Shrader, B. (1989) Transforming growth factor ␤ specifically enhances IgA production by lipopolysaccharidestimulated murine B lymphocytes. J. Exp. Med. 170, 1039 –1044. Kim, P. H., Kagnoff, M. F. (1990) Transforming growth factor-␤ 1 is a costimulator for IgA production. J. Immunol. 144, 3411–3416. Shockett, P., Stavnezer, J. (1991) Effect of cytokines on switching to IgA and ␣ germline transcripts in the B lymphoma I.29 ␮. Transforming growth factor-␤ activates transcription of the unrearranged C ␣ gene. J. Immunol. 147, 4374 – 4383. Snapper, C. M., Peschel, C., Paul, W. E. (1988) IFN-␥ stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140, 2121–2127. Bossie, A., Vitetta, E. S. (1991) IFN-␥ enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-␥ in class switching. Cell. Immunol. 135, 95–104. Sasaki, Y., Casola, S., Kutok, J. L., Rajewsky, K., Schmidt-Supprian, M. (2004) TNF family member B cell-activating factor (BAFF) receptordependent and -independent roles for BAFF in B cell physiology. J. Immunol. 173, 2245–2252.


1439